Search filters

List of works by Eiki Ichihara

A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome

scientific article published on January 2013

A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene

scientific article published on 28 August 2014

A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202.

scientific article published on 12 August 2017

Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model

scientific article published on 26 February 2013

Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors

scientific article published on 10 July 2020

Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice

scientific article published on 18 August 2009

Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult

scientific article published on October 2007

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC).

scientific article published on August 2017

Discomfort during bronchoscopy performed after endobronchial intubation with fentanyl and midazolam: a prospective study

scientific article published on 23 February 2017

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model

scientific article published on 29 October 2013

Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation

scientific article published on August 2016

Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells

scientific article

Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo

scientific article

Establishment of pemetrexed-resistant non-small cell lung cancer cell lines

scientific article published on 24 June 2011

Everolimus prolonged survival in transgenic mice with EGFR-driven lung tumors

scientific article published on 25 April 2014

Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience

scientific article published on 16 March 2014

Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703.

scientific article

Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations

scientific article published in July 2013

Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response

scientific article published on 31 July 2012

JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation

scientific article

Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells

scientific article published on 28 June 2011

Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model

scientific article published on 25 October 2013

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

scientific article published on 30 December 2015

Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403.

scientific article published on 9 July 2016

Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.

scientific article published in March 2015

Potential influence of being overweight on the development of hepatic dysfunction in Japanese patients with EGFR-mutated non-small cell lung cancer undergoing gefitinib monotherapy: the Okayama Lung Cancer Study Group experience

scientific article published on 2 September 2016

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

scientific article

Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease

scientific article published in October 2017

Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).

scientific article published on 2 June 2016

Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002.

scientific article published on 29 September 2013

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

scientific article

Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.

scientific article published on 21 June 2015

Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer

scientific article published on 15 January 2014

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

scientific article

Synchronous pulmonary MALT lymphoma and pulmonary adenocarcinoma after metachronous gastric MALT lymphoma and gastric adenocarcinoma

scientific article published in November 2008

Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells

scientific article

Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.

scientific article

Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades

scientific article

Triplet therapy with afatinib, cetuximab, and bevacizumab induces deep remission in lung cancer cells harboring EGFR T790M in vivo

scientific article

Utility of immune checkpoint inhibitors in non-small-cell lung cancer patients with poor performance status

scientific article published on 29 July 2020

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers

scientific article published on 07 January 2021

Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiency

scientific article

Paulina is supported by:

About Paulina

Help